Order Now, Ships Today
One-time
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Klow 30mg is a research-grade multi-peptide blend supplied as a lyophilized powder in a sterile vial. The blend combines four well-characterized synthetic peptides under investigation for complementary pathways: BPC-157, TB-500 (thymosin beta-4 fragment), GHK-Cu (copper tripeptide) and KPV (Lys-Pro-Val tripeptide), with a total peptide content of 30 mg per vial.
Each batch of Klow 30mg is released at ≥98–99% purity (combined peptide content) as confirmed by HPLC and/or LC-MS. The lot-specific Certificate of Analysis documents: Identity of each component peptide (BPC-157, TB-500, GHK-Cu, KPV) Total content of 30 mg/vial Purity profile and peak integration Appearance (white/off-white lyophilized powder) Residual solvent and moisture content within internal limits This material is labeled and supplied strictly for laboratory research use only. Shengyufan +2 Prime Lab Peptides +2
Products from Elite Miami Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Each vial contains exactly what’s indicated on the label. For instance, a 10mg vial contains precisely 10mg of lyophilized peptide. Researchers may divide it into smaller research portions—such as four 2.5mg aliquots—but the total content remains the same.
Yes. All peptides are supplied in lyophilized powder form and do not come reconstituted. Any extra materials required for research, such as solvents or diluents, must be obtained separately.
When stored as a dry powder, peptides remain stable for up to 2 years.
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions.
Klow 30mg combines peptides frequently studied in tissue-repair, extracellular matrix, angiogenesis and inflammation models: BPC-157: a gastric-derived peptide fragment explored in gastro-intestinal, tendon and ligament models. Peptide Sciences +1 TB-500/Tβ4 fragment: derived from thymosin beta-4, widely used to investigate cell migration, actin remodeling and wound-healing pathways. Ameano Peptides GHK-Cu: a naturally occurring copper-binding tripeptide associated with collagen synthesis, matrix remodeling and skin-biology research. Echemi +1 KPV: an α-MSH–related tripeptide evaluated in models of inflammatory signalling and epithelial barrier function. Ameano Peptides By combining these peptides in a single vial, Klow 30mg is positioned as a tool compound for exploring multi-pathway effects in tissue, skin and musculoskeletal research systems. Peptide Sciences +1
Klow 30mg is essentially a “combo vial” for the lab: instead of testing each peptide separately, researchers can look at what happens when four commonly studied peptides are present together. In different experimental setups, these components are used to study how cells move, how new blood vessels form, how collagen and extracellular matrix are regulated, and how inflammatory signals change. It is not a drug or supplement and is provided only for controlled research, not for human use.
⚠️ Disclaimer: this product is not approved for medical use and is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and research purposes only, and this product must never be used in humans or animals.
The individual components of Klow 30mg have been used as stand-alone research peptides for many years across musculoskeletal, dermatologic and inflammatory models. As interest grew in “blend” or “stacked” peptides, several suppliers introduced multi-component vials such as Glow (BPC-157/TB-500/GHK-Cu) and Klow, which adds KPV as a fourth peptide to broaden the mechanistic coverage toward inflammation and epithelial signalling.
Klow 30mg is not a single peptide but a mixture of four distinct lyophilized peptides in one vial: BPC-157: a 15-amino-acid fragment (sequence derived from body-protection compound) TB-500: a thymosin beta-4–derived fragment containing the actin-binding motif GHK-Cu: the tripeptide glycyl-L-histidyl-L-lysine complexed with a Cu²⁺ ion KPV: the tripeptide Lys-Pro-Val, related to the C-terminal sequence of α-MSH Each component retains its own primary sequence and molecular weight; no covalent linkage between peptides is implied in the blend.
Preclinical studies of the individual components report: BPC-157: modulation of angiogenic markers, fibroblast activity and gastro-intestinal lining integrity in various in-vitro and in-vivo models. TB-500/Tβ4 fragment: enhanced cell migration, cytoskeletal reorganization, and support of tissue repair in cardiac, corneal and dermal models. GHK-Cu: up-regulation of collagen and glycosaminoglycan synthesis, improved dermal matrix markers and antioxidant signalling in skin and hair-follicle systems. KPV: suppression of selected pro-inflammatory cytokines and support of epithelial barrier markers in gut and skin models. Gen Pharma Peptides +3 Ameano Peptides +3 Revolution Health & Wellness +3 As a blend, Klow-type formulations are being used to test whether combining these mechanisms yields additive or synergistic effects on wound-healing surrogates, matrix remodeling, and inflammatory-response readouts in experimental settings. Peer-reviewed data specifically on the exact commercial “Klow 30mg” formulation are still limited; most evidence is extrapolated from studies on each peptide alone.
In practice, scientists use Klow-style blends when they want to hit several “repair-related” pathways at once instead of running four separate peptides. Early findings with the individual components look promising in lab and animal models for things like matrix quality, new vessel formation and inflammatory signalling, but this remains experimental science. None of this establishes safety or effectiveness for treating injuries or skin concerns in humans, and Klow 30mg is sold strictly as a research material.
Supplier and catalog descriptions for Klow/GHK-Cu/BPC-157/TB-500/KPV blends and related multi-peptide vials. Peptide Sciences +2 Ameano Peptides +2 Reviews and primary research on BPC-157, TB-500/Tβ4, GHK-Cu and KPV in tissue, skin and inflammatory models
Our specialists respond within minutes to any order or product inquiry.
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
By clicking the button above, you agree to receive marketing text messages from Elite Miami Peptides at the number provided. Consent is not a condition of purchase. Msg & data rates may apply. Reply STOP to cancel, HELP for help. View our Privacy Policy.
All compounds from Elite Miami Peptides are intended strictly for laboratory research purposes.
They are not for human use, consumption, or therapeutic applications.
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
